Literature DB >> 8213543

Predictors and long-term prognostic significance of recurrent infarction in the year after a first myocardial infarction. SPRINT Study Group.

R Kornowski1, U Goldbourt, M Zion, L Mandelzweig, E Kaplinsky, Y Levo, S Behar.   

Abstract

This study was undertaken to examine whether clinical factors predict reinfarction within 1 year of a first acute myocardial infarction (AMI) and to quantify the subsequent influence of reinfarction on long-term mortality. Data from 3,695 patients with a first AMI included in the Secondary Prevention Reinfarction Israeli Nifedipine Trial Registry were analyzed. The 1-year reinfarction incidence was 6.0% (220 of 3,695) and in-hospital mortality during reinfarction was 31%. Patients with reinfarction were older (63.0 vs 60.8 years) at entry. The independent clinical predictors for 1-year reinfarction were (adjusted relative odds): peripheral vascular disease (2.12), anterior location of the first AMI (1.62), angina before the first AMI (1.53), congestive heart failure on admission (1.34), diabetes (1.33), systemic hypertension (1.28) and age increment (1.13). One-year reinfarction rate increased from 4.0% in patients with 0 or 1 risk factor to 23.3% in patients with 5 to 6 risk factors (p < 0.0001). Patients with reinfarction had significantly increased 1- and 5-year mortality compared with those who had no reinfarction (11.8 vs 5.3% and 40.1 vs 20.3%, respectively, p < 0.001). Recurrent AMI within 1 year was the most powerful predictor of long-term (mean 5.5 years) total mortality (adjusted relative risk = 4.76).

Entities:  

Mesh:

Year:  1993        PMID: 8213543     DOI: 10.1016/0002-9149(93)91100-v

Source DB:  PubMed          Journal:  Am J Cardiol        ISSN: 0002-9149            Impact factor:   2.778


  8 in total

1.  Current and Practical Management of Acute Myocardial Infarction.

Authors: 
Journal:  J Thromb Thrombolysis       Date:  1997       Impact factor: 2.300

2.  Temporal decline in the prognostic impact of a recurrent acute myocardial infarction 1985 to 2002.

Authors:  P Buch; S Rasmussen; G H Gislason; J N Rasmussen; L Køber; N Gadsbøll; S Stender; M Madsen; C Torp-Pedersen; S Z Abildstrom
Journal:  Heart       Date:  2006-08-29       Impact factor: 5.994

Review 3.  Indications of combined vitamin K antagonists and aspirin therapy.

Authors:  A Loualidi; S H J Bredie; M C H Janssen
Journal:  J Thromb Thrombolysis       Date:  2008-05-31       Impact factor: 2.300

4.  Prognostic significance of nonfatal myocardial reinfarction in survivors of a first infarction.

Authors:  R T van Domburg; J W Deckers; P F M M van Bergen; A J Azar; J J C Jonker; M L Simoons
Journal:  Neth Heart J       Date:  2001-08       Impact factor: 2.380

5.  Prognostic Importance of Previous Myocardial Infarction in Patients Receiving Thrombolytic Therapy for Acute Infarction.

Authors: 
Journal:  J Thromb Thrombolysis       Date:  1996       Impact factor: 2.300

6.  Clinical features of early recurrent myocardial infarction.

Authors:  Kenichi Sakakura; Norifumi Kubo; Junya Ako; Nahoko Ikeda; Hiroshi Funayama; Taishi Hirahara; Hiroshi Wada; Yoshitaka Sugawara; Takanori Yasu; Masanobu Kawakami; Shin-ichi Momomura
Journal:  Heart Vessels       Date:  2009-09-27       Impact factor: 2.037

7.  Effects of timing, location and definition of reinfarction on mortality in patients with totally occluded infarct related arteries late after myocardial infarction.

Authors:  Christopher Adlbrecht; Kurt Huber; Harmony R Reynolds; Antonio C Carvalho; Vladimír Džavík; Philippe Gabriel Steg; Li Liu; Paolo Marino; Camille A Pearte; James M Rankin; Harvey D White; Gervasio A Lamas; Judith S Hochman
Journal:  Int J Cardiol       Date:  2014-03-28       Impact factor: 4.164

8.  Change in Pulse Wave Velocity and Short-Term Development of Cardiovascular Events in the Hemodialysis Population.

Authors:  Serge Korjian; Yazan Daaboul; Balsam El-Ghoul; Salam Samad; Pascale Salameh; Georges Dahdah; Essa Hariri; Anthony Mansour; Kathryn Spielman; Jacques Blacher; Michel E Safar; Sola Aoun Bahous
Journal:  J Clin Hypertens (Greenwich)       Date:  2016-05-25       Impact factor: 3.738

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.